Literature DB >> 16000704

Phage therapy: the Escherichia coli experience.

Harald Brüssow1.   

Abstract

Phages have been proposed as natural antimicrobial agents to fight bacterial infections in humans, in animals or in crops of agricultural importance. Phages have also been discussed as hygiene measures in food production facilities and hospitals. These proposals have a long history, but are currently going through a kind of renaissance as documented by a spate of recent reviews. This review discusses the potential of phage therapy with a specific example, namely Escherichia coli.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000704     DOI: 10.1099/mic.0.27849-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  72 in total

1.  Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.

Authors:  Alex R Hall; Daniel De Vos; Ville-Petri Friman; Jean-Paul Pirnay; Angus Buckling
Journal:  Appl Environ Microbiol       Date:  2012-06-01       Impact factor: 4.792

2.  Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters.

Authors:  Jeremy J Barr; Rita Auro; Nicholas Sam-Soon; Sam Kassegne; Gregory Peters; Natasha Bonilla; Mark Hatay; Sarah Mourtada; Barbara Bailey; Merry Youle; Ben Felts; Arlette Baljon; Jim Nulton; Peter Salamon; Forest Rohwer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

3.  Genome sequence and characterization of the Tsukamurella bacteriophage TPA2.

Authors:  Steve Petrovski; Robert J Seviour; Daniel Tillett
Journal:  Appl Environ Microbiol       Date:  2010-12-23       Impact factor: 4.792

4.  Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy.

Authors:  Timothy K Lu; James J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

Review 5.  Enhancing the utility of existing antibiotics by targeting bacterial behaviour?

Authors:  Geraint B Rogers; Mary P Carroll; Kenneth D Bruce
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

6.  Characterization of Salmonella bacteriophages isolated from swine lagoon effluent.

Authors:  Michael R McLaughlin; Rodney A King
Journal:  Curr Microbiol       Date:  2007-11-10       Impact factor: 2.188

7.  A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.

Authors:  J J Bull; E R Vimr; I J Molineux
Journal:  Virology       Date:  2009-12-16       Impact factor: 3.616

8.  Vibrio vulnificus bacteriophage SSP002 as a possible biocontrol agent.

Authors:  Hyun Sung Lee; Slae Choi; Hakdong Shin; Ju-Hoon Lee; Sang Ho Choi
Journal:  Appl Environ Microbiol       Date:  2013-11-08       Impact factor: 4.792

9.  Phage Therapy - Everything Old is New Again.

Authors:  Andrew M Kropinski
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

Review 10.  Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.

Authors:  Adelaide Almeida; Angela Cunha; Newton C M Gomes; Eliana Alves; Liliana Costa; Maria A F Faustino
Journal:  Mar Drugs       Date:  2009-07-30       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.